187 related articles for article (PubMed ID: 11271407)
1. Contribution of the active metabolite, norcocaine, to cocaine's effects after intravenous and oral administration in rats: pharmacodynamics.
Wang Q; Simpao A; Sun L; Falk JL; Lau CE
Psychopharmacology (Berl); 2001 Jan; 153(3):341-52. PubMed ID: 11271407
[TBL] [Abstract][Full Text] [Related]
2. Cocaine pharmacodynamics after intravenous and oral administration in rats: relation to pharmacokinetics.
Ma F; Falk JL; Lau CE
Psychopharmacology (Berl); 1999 Jun; 144(4):323-32. PubMed ID: 10435404
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous pharmacokinetic modeling of cocaine and its metabolites, norcocaine and benzoylecgonine, after intravenous and oral administration in rats.
Sun L; Lau CE
Drug Metab Dispos; 2001 Sep; 29(9):1183-9. PubMed ID: 11502725
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic determinants of cocaine's differential effects on locomotor and operant behavior.
Lau CE; Wang Y; Sun L; Lobarinas E; Wang Q; Nguyen KN; Falk JL
Eur J Pharmacol; 1999 Sep; 381(2-3):85-92. PubMed ID: 10554874
[TBL] [Abstract][Full Text] [Related]
5. Oral cocaine pharmacokinetics and pharmacodynamics in a cumulative-dose regimen: pharmacokinetic-pharmacodynamic modeling of concurrent operant and spontaneous behavior within an operant context.
Lau CE; Sun L; Wang Q; Simpao A; Falk JL
J Pharmacol Exp Ther; 2000 Nov; 295(2):634-43. PubMed ID: 11046099
[TBL] [Abstract][Full Text] [Related]
6. Physiological, subjective and reinforcing effects of oral and intravenous cocaine in humans.
Smith BJ; Jones HE; Griffiths RR
Psychopharmacology (Berl); 2001 Aug; 156(4):435-44. PubMed ID: 11498721
[TBL] [Abstract][Full Text] [Related]
7. Sensitization to cocaine's reinforcing effects produced by various cocaine pretreatment regimens in rats.
Schenk S; Partridge B
Pharmacol Biochem Behav; 2000 Aug; 66(4):765-70. PubMed ID: 10973514
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL
Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698
[TBL] [Abstract][Full Text] [Related]
9. Effects of cocaine and cocaine metabolites on cardiovascular function in squirrel monkeys.
Schindler CW; Zheng JW; Goldberg SR
Eur J Pharmacol; 2001 Nov; 431(1):53-9. PubMed ID: 11716843
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic modeling of the psychomotor stimulant effect of cocaine after intravenous administration: timing performance deficits.
Lau CE; Ma F; Foster DM; Falk JL
J Pharmacol Exp Ther; 1999 Feb; 288(2):535-43. PubMed ID: 9918556
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists.
Costanza RM; Barber DJ; Terry P
Psychopharmacology (Berl); 2001 Nov; 158(2):146-53. PubMed ID: 11702088
[TBL] [Abstract][Full Text] [Related]
12. Citalopram enhances cocaine's subjective effects in rats.
Soto PL; Hiranita T; Katz JL
Behav Pharmacol; 2009 Dec; 20(8):759-62. PubMed ID: 20195220
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of the reinforcing effects of self-administered cocaine in rats: effects of dose and intravenous injection speed.
Liu Y; Roberts DC; Morgan D
Eur J Neurosci; 2005 Jul; 22(1):195-200. PubMed ID: 16029209
[TBL] [Abstract][Full Text] [Related]
14. Arteriovenous serum cocaine concentration difference after intravenous bolus injection and constant-rate infusions: relation to pharmacodynamic estimates in rats.
Sun L; Lau CE
Eur J Pharm Sci; 2001 Dec; 14(4):261-9. PubMed ID: 11684400
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cocaine reinforcement in lean and obese Zucker rats: Relative potency and reinstatement of extinguished operant responding.
Townsend EA; Freeman KB
Physiol Behav; 2017 Mar; 170():88-92. PubMed ID: 27998754
[TBL] [Abstract][Full Text] [Related]
16. Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats.
Ratzenboeck E; Saria A; Kriechbaum N; Zernig G
Pharmacology; 2001; 62(3):138-44. PubMed ID: 11287814
[TBL] [Abstract][Full Text] [Related]
17. Possible novel pharmacodynamic action of cocaine: cardiovascular and behavioral evidence.
Tella SR
Pharmacol Biochem Behav; 1996 Jun; 54(2):343-54. PubMed ID: 8743594
[TBL] [Abstract][Full Text] [Related]
18. Comparative behavioral profile of cocaine and norcocaine in rats and monkeys.
Bedford JA; Borne RF; Wilson MC
Pharmacol Biochem Behav; 1980 Jul; 13(1):69-75. PubMed ID: 6773074
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous activity as a contingency-controlled behavior within an operant context: alprazolam concentration-effect relations after subcutaneous administration in rats.
Simpao A; Sun L; Falk JL; Lau CE
Psychopharmacology (Berl); 2001 May; 155(3):269-77. PubMed ID: 11432689
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to cocaine's effects on schedule-controlled behavior: role of delay between pause-ending responses and reinforcement.
Macaskill AC; Branch MN
Pharmacol Biochem Behav; 2012 Jan; 100(3):616-23. PubMed ID: 22079348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
